Correction: Development and 
        in vitro and 
        ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization.: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h)

Muhammad Sarfraz; Gautam Behl; Sweta Rani; Niall O'Reilly; Peter McLoughlin; Orla O'Donovan; Alison L Reynolds; John Lynch; Laurence Fitzhenry

doi:10.1039/d5na90032h

Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization. Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h)

Muhammad Sarfraz
, Gautam Behl
, Sweta Rani
, Niall O'Reilly
, Peter McLoughlin
, Orla O'Donovan
, Alison L Reynolds
, John Lynch
, Laurence Fitzhenry

Research output: Contribution to journal › Comment/debate

Abstract

The authors regret that the incorrect spelling of the name of author Gautam Behl was used in this manuscript. The corrected spelling for this author name is as above. All affiliations for this author remain the same. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Original language	English
Pages (from-to)	3143
Journal	Nanoscale Advances
Volume	7
Issue number	10
DOIs	https://doi.org/10.1039/d5na90032h
Publication status	Published - 01 Jan 2025

Access to Document

10.1039/d5na90032h

Fingerprint

Dive into the research topics of 'Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization. Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h)'. Together they form a unique fingerprint.

Cite this

Sarfraz, M., Behl, G., Rani, S., O'Reilly, N., McLoughlin, P., O'Donovan, O., Reynolds, A. L., Lynch, J., & Fitzhenry, L. (2025). Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization. Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h). Nanoscale Advances, 7(10), 3143. https://doi.org/10.1039/d5na90032h

Sarfraz, Muhammad ; Behl, Gautam ; Rani, Sweta et al. / Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization. Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h). In: Nanoscale Advances. 2025 ; Vol. 7, No. 10. pp. 3143.

@article{4d1f8abd01bc4f698c62e59579bab335,

title = "Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization.: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h)",

abstract = "The authors regret that the incorrect spelling of the name of author Gautam Behl was used in this manuscript. The corrected spelling for this author name is as above. All affiliations for this author remain the same. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.",

author = "Muhammad Sarfraz and Gautam Behl and Sweta Rani and Niall O'Reilly and Peter McLoughlin and Orla O'Donovan and Reynolds, \{Alison L\} and John Lynch and Laurence Fitzhenry",

note = "Publisher Copyright: {\textcopyright} 2025 The Author(s). Published by the Royal Society of Chemistry.",

year = "2025",

month = jan,

day = "1",

doi = "10.1039/d5na90032h",

language = "English",

volume = "7",

pages = "3143",

journal = "Nanoscale Advances",

issn = "2516-0230",

publisher = "Royal Society of Chemistry",

number = "10",

}

Sarfraz, M, Behl, G, Rani, S , O'Reilly, N, McLoughlin, P, O'Donovan, O, Reynolds, AL, Lynch, J & Fitzhenry, L 2025, 'Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization. Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h)', Nanoscale Advances, vol. 7, no. 10, pp. 3143. https://doi.org/10.1039/d5na90032h

Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization. Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h). / Sarfraz, Muhammad; Behl, Gautam; Rani, Sweta et al.
In: Nanoscale Advances, Vol. 7, No. 10, 01.01.2025, p. 3143.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization.

T2 - Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h)

AU - Sarfraz, Muhammad

AU - Behl, Gautam

AU - Rani, Sweta

AU - O'Reilly, Niall

AU - McLoughlin, Peter

AU - O'Donovan, Orla

AU - Reynolds, Alison L

AU - Lynch, John

AU - Fitzhenry, Laurence

PY - 2025/1/1

Y1 - 2025/1/1

N2 - The authors regret that the incorrect spelling of the name of author Gautam Behl was used in this manuscript. The corrected spelling for this author name is as above. All affiliations for this author remain the same. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

AB - The authors regret that the incorrect spelling of the name of author Gautam Behl was used in this manuscript. The corrected spelling for this author name is as above. All affiliations for this author remain the same. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

UR - https://www.scopus.com/pages/publications/105004030748

U2 - 10.1039/d5na90032h

DO - 10.1039/d5na90032h

M3 - Comment/debate

C2 - 40322461

SN - 2516-0230

VL - 7

SP - 3143

JO - Nanoscale Advances

JF - Nanoscale Advances

IS - 10

ER -

Sarfraz M, Behl G, Rani S , O'Reilly N, McLoughlin P, O'Donovan O et al. Correction: Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization. Development and in vitro and ex vivo characterization of a twin nanoparticulate system to enhance ocular absorption and prolong retention of dexamethasone in the eye: from lab to pilot scale optimization (Nanoscale Advances (2025) DOI: 10.1039/d4na01086h). Nanoscale Advances. 2025 Jan 1;7(10):3143. doi: 10.1039/d5na90032h

Abstract

Access to Document

Other files and links

Fingerprint

Cite this